Evidence map›Paper›PMID 40259421›Full record

ArticleJournal of cheminformatics2025

Learning motif features and topological structure of molecules for metabolic pathway prediction.

Jianguo Hu, Yiqing Zhang, Jinxin Xie, Zhen Yuan, Zhangxiang Yin, Shanshan Shi, Honglin Li, Shiliang Li

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jianguo Hu *Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, China.
Yiqing Zhang *Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, China.
Jinxin XieShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, China.
Zhen YuanShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, China.
Zhangxiang YinShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, China.
Shanshan ShiShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, China.
Honglin LiShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, China. hlli@ecust.edu.cn.
Shiliang LiShanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, China. slli403@163.com.

Funding

National Natural Science Foundation of China 82173690National Natural Science Foundation of China 82425104
6 · The paper itself

Abstract

Metabolites serve as crucial biomarkers for assessing disease progression and understanding underlying pathogenic mechanisms. However, when the metabolic pathway category of metabolites is unknown, researchers face challenges in conducting metabolomic analyses. Due to the complexity of wet laboratory experimentation for pathway identification, there is a growing demand for predictive methods. Various computational approaches, including machine learning and graph neural networks, have been proposed; however, interpretability remains a challenge. We have developed a neural network framework called MotifMol3D, which is designed for predicting molecular metabolic pathway categories. This framework introduces motif information to mine local features of small-sample molecules, combining with graph neural network and 3D information to complete the prediction task. Using a dataset of 5,698 molecules that participate in 11 metabolic pathway categories in the KEGG database, MotifMol3D outperformed state-of-the-art methods in precision, recall, and F1 score. In addition, ablation study and motif analysis have demonstrated the effectiveness and usefulness of the model. Motif analysis, in particular, has shown motif information can actually characterize the main features of specific pathway molecules to a certain extent and enhance the interpretability of the model. An external validation further corroborates this observation. MotifMol3D is an open-source tool that is available at https://github.com/Irena-Zhang/MotifMol3D.git .Scientific contribution MotifMol3D integrates motif information, graph neural networks, and 3D structural data to enhance feature extraction for small-sample molecules, improving the precision and interpretability of metabolic pathway predictions. The model outperforms state-of-the-art approaches in precision, recall, and F1 score. This work reveals how motif information characterizes pathway-specific molecules, offering novel insights into molecular properties within metabolic pathways.

Identifiers

PMID40259421
PMCPMC12013036

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.